Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vericel Corp (NASDAQ:VCEL)

1.82
Delayed Data
As of 11:47am ET
 +0.035 / +1.96%
Today’s Change
1.69
Today|||52-Week Range
4.35
-29.46%
Year-to-Date
No recent news for Vericel Corp.

Today’s Trading

Previous close1.79
Today’s open1.81
Day’s range1.76 - 1.82
Volume15,320
Average volume (3 months)58,255
Market cap$42.5M
Dividend yield--
Data as of 11:47am ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+67.91%
Earnings growth (this year)+62.78%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+151,457.89%
P/E ratioNM
Price/Sales1.23
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CAPRCapricor Therapeutic...+0.00+0.18%
CPXXCelator Pharmaceutic...+0.10+8.40%
MICBMicrolin Bio Inc0.000.00%
SBOTStellar Biotechnolog...+0.19+3.50%
Data as of 11:46am ET, 02/12/2016

Financials

Next reporting dateMarch 22, 2016
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$28.8M
Annual profit (last year)-$19.9M
Net profit margin-69.18%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Dominick C. Colangelo
Chief Operating Officer
Daniel R. Orlando
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers